3xTg-AD mice infused with aCSF consistently showed decreased phospho-TrkB levels compared with aCSF-treated wild-type mice, but administration of GQ1b significantly increased phospho-TrkB levels in the hippocampus of 3xTg-AD mice (Fig. 3E). This evidence concerns the gene NTRK2 and Alzheimer disease.